Anna Lee

Mar 21, 2025 | pharmacytoday.co.nz | Noni Richards |Patrice Dougan |Anna Lee

+News Successful Hawke’s Bay gout programme has staff cut One of the 11 pharmacies involved in Mate Taihā, Unichem Waipukurau Pharmacy’s Charles Nairn [Image: Supplied]  ESSENTIALS  , A Hawke’s Bay gout treatment programme for tāne Māori (Māori men) has had two roles made redundant, leaving the programme's future success in doubt. , BACK panel - grey Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā Not a subscriber? Unlock this article by subscribing here.

Nov 15, 2024 | mytravaly.com | Anna Lee

Cabergoline is a medication that has gained significant attention in the medical community for its ability to influence libido and intimacy in both men and women. Often prescribed in doses of Cabergoline 0.5 mg or Cabergoline 0.25 mg, Cabergoline is a dopamine agonist with several uses, one of the most notable being its effect on sexual function. But what makes Cabergoline so unique, and how does it contribute to enhancing libido?

Nov 12, 2024 | onlinelibrary.wiley.com | Won-Oak Oh |Insun Yeom |Anna Lee |Jihee Han

Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description nhs13192-sup-0001-FigureS1.docxWord 2007 document , 53.4 KB Figure S1: Theoretical concept of this study. References 1987. “Unraveling the Mystery of Health: How People Manage Stress and Stay Well.” Jossey-Bass. , and . 2014. “Development and Validity Study of the Daily Stress Response Inventory for Adolescent.” Korean Journal of School Psychology 11, no.

Sep 2, 2024 | pharmacytoday.co.nz | Natasha Jojoa Burling |Paulette Crowley |Anna Lee |Steve Hart

Nataly Martini provides a brief overview of selected causes of dizziness and vertigo, such as benign paroxysmal positional vertigo and vestibular migraine. Through case studies, she explains how these conditions may differ from serious clinical syndromes such as cervicogenic dizziness, highlighting the complexities, risk factors and management of these conditions

Jul 28, 2024 | pharmacytoday.co.nz | Chris Valli |Paulette Crowley |Anna Lee |Madeleine Fountain

Adult attention deficit hyperactivity disorder is a fairly new and exciting area of research in psychiatry. In this article, Sidhesh Phaldessai examines our increasing understanding of the symptom presentation and management of this neurodevelopmental disorder in adults